Cargando…

Influence of Nicotine Metabolism Ratio on [(11)C]-(+)-PHNO PET Binding in Tobacco Smokers

BACKGROUND: Identifying the biological basis of smoking cessation success is of growing interest. The rate of nicotine metabolism, measured by the nicotine metabolite ratio, affects multiple aspects of nicotine dependence. Fast nicotine metabolizers tend to smoke more, experience more withdrawal and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Ciano, Patricia, Tyndale, Rachel F, Mansouri, Esmaeil, Hendershot, Christian S, Wilson, Alan A, Lagzdins, Dina, Houle, Sylvain, Boileau, Isabelle, Le Foll, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Regular Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007643/ https://www.ncbi.nlm.nih.gov/pubmed/29346545 http://dx.doi.org/10.1093/ijnp/pyx119

Ejemplares similares

The influence of conditioned stimuli on [(11)C]-(+)-PHNO PET binding in tobacco smokers after a one week abstinence
por: Di Ciano, Patricia, et al.
Publicado: (2021)

Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [(11)C]-(+)-PHNO study
por: Chukwueke, Chidera C., et al.
Publicado: (2021)

Presentation of Smoking-Associated Cues Does Not Elicit Dopamine Release after One-Hour Smoking Abstinence: A [(11)C]-(+)-PHNO PET Study
por: Chiuccariello, Lina, et al.
Publicado: (2013)

Functional Connectivity of the Raphe Nuclei: Link to Tobacco Withdrawal in Smokers
por: Faulkner, Paul, et al.
Publicado: (2018)

Motor Synchronization to Rhythmic Auditory Stimulation (RAS) Attenuates Dopaminergic Responses in Ventral Striatum in Young Healthy Adults: [(11)C]-(+)-PHNO PET Study
por: Koshimori, Yuko, et al.
Publicado: (2019)

Personalized dosing of nicotine replacement therapy versus standard dosing for the treatment of individuals with tobacco dependence: study protocol for a randomized placebo-controlled trial
por: Zawertailo, Laurie, et al.
Publicado: (2020)

The CB1R rs2023239 receptor gene variant significantly affects the reinforcing effects of nicotine, but not cue reactivity, in human smokers
por: Chukwueke, Chidera C., et al.
Publicado: (2020)

Pregnant Smokers Receiving Opioid Agonist Therapy Have an Elevated Nicotine Metabolite Ratio: A Replication Study
por: Kranzler, Henry R, et al.
Publicado: (2020)

Response to reduced nicotine content cigarettes among smokers with chronic health conditions
por: Streck, Joanna M., et al.
Publicado: (2018)

Melatonin for Treatment-Seeking Alcohol Use Disorder patients with sleeping problems: A randomized clinical pilot trial
por: Gendy, Marie N. S., et al.
Publicado: (2020)

Testing the PPAR hypothesis of tobacco use disorder in humans: A randomized trial of the impact of gemfibrozil (a partial PPARα agonist) in smokers
por: Gendy, Marie N. S., et al.
Publicado: (2018)

Genetic and Pharmacokinetic Determinants of Response to Transdermal Nicotine in White, Black and Asian Non-Smokers
por: Dempsey, Delia A., et al.
Publicado: (2013)

Randomized controlled trial of mailed Nicotine Replacement Therapy to Canadian smokers: study protocol
por: Cunningham, John A, et al.
Publicado: (2011)

Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development
por: Le Foll, Bernard, et al.
Publicado: (2014)

Circulating Endocannabinoids and N-Acylethanolamines in Individuals with Cannabis Use Disorder—Preliminary Findings
por: Boachie, Nadia, et al.
Publicado: (2023)

Disparities in knowledge and use of tobacco treatment among smokers in California following healthcare reform
por: Young-Wolff, Kelly C., et al.
Publicado: (2019)

Variation in Trans-3′-Hydroxycotinine Glucuronidation Does Not Alter the Nicotine Metabolite Ratio or Nicotine Intake
por: Zhu, Andy Z. X., et al.
Publicado: (2013)

Toward the Optimization of (+)-[(11)C]PHNO Synthesis: Time Reduction and Process Validation
por: Pfaff, Sarah, et al.
Publicado: (2019)

Nicotine replacement therapy to aid gradual cessation in smokers with no intention to quit: Association between reduction quantity and later abstinence
por: Cheung, Yee Tak Derek, et al.
Publicado: (2015)

Comparison of Dopamine D(3) and D(2) Receptor Occupancies by a Single Dose of Blonanserin in Healthy Subjects: A Positron Emission Tomography Study With [(11)C]-(+)-PHNO
por: Tateno, Amane, et al.
Publicado: (2018)

Biomarkers of Tobacco Exposure Decrease After Smokers Switch to an E-Cigarette or Nicotine Gum
por: Round, Elaine K, et al.
Publicado: (2018)

PM476. d-Amphetamine-induced sensitization of the dopaminergic system in healthy human subjects: A [(11)C]-(+)-PHNO-PET study
por: Ana, Popovic, et al.
Publicado: (2016)

The relationship between childhood trauma, dopamine release and dexamphetamine-induced positive psychotic symptoms: a [(11)C]-(+)-PHNO PET study
por: Dahoun, Tarik, et al.
Publicado: (2019)

Dopamine genes and nicotine dependence in treatment seeking and community smokers
por: Bergen, Andrew W., et al.
Publicado: (2009)

Catabolism and Detoxification of 1-Aminoalkylphosphonic Acids: N-Acetylation by the phnO Gene Product
por: Hove-Jensen, Bjarne, et al.
Publicado: (2012)

Perceptions of oral nicotine pouches & their marketing among Ohio Appalachia smokers and smokeless tobacco users
por: Long, Lauren, et al.
Publicado: (2023)

Influence of gender on initiation of tobacco and nicotine containing product use among U.S. Air Force trainees
por: Patten, Christi A., et al.
Publicado: (2020)

The relationship between type of telephone service and smoking cessation among rural smokers enrolled in quitline tobacco dependence treatment
por: Nemeth, Julianna M., et al.
Publicado: (2017)

Hardening determinants among adult daily smokers in nine African countries: Data from the Global Adult Tobacco Survey
por: Sreeramareddy, Chandrashekhar T, et al.
Publicado: (2023)

Perceptions of emerging tobacco products and nicotine replacement therapy among pregnant women and women planning a pregnancy()
por: England, Lucinda J., et al.
Publicado: (2016)

Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [(11)C]PHNO PET
por: Rabiner, Eugenii A., et al.
Publicado: (2021)

Nicotin in Tobacco
Publicado: (1913)

The Network Structure of Tobacco Withdrawal in a Community Sample of Smokers Treated With Nicotine Patch and Behavioral Counseling
por: Lydon-Staley, David M, et al.
Publicado: (2018)

A screening approach for the evaluation of tobacco-free ‘modern oral’ nicotine products using Real Time Cell Analysis
por: East, N., et al.
Publicado: (2021)

Prospective predictors of electronic nicotine delivery system initiation in tobacco naive young adults: A machine learning approach
por: Atuegwu, Nkiruka C., et al.
Publicado: (2023)

Addiction to the nicotine gum in never smokers
por: Etter, Jean-François
Publicado: (2007)

Trends in cigarette, cigar, and smokeless tobacco use among New York City public high school youth smokers, 2001–2013
por: Elfassy, Tali, et al.
Publicado: (2015)

Concentrated Distribution of Nicotine Patches to a Town With High Smoking Rates—Any Evidence of Large Impacts on Tobacco Cessation?
por: Cunningham, John A, et al.
Publicado: (2022)

Evaluation of dopamine D(3) receptor occupancy by blonanserin using [(11)C]-(+)-PHNO in schizophrenia patients
por: Sakayori, Takeshi, et al.
Publicado: (2020)

Validation of a LC-MS/MS Method for Quantifying Urinary Nicotine, Six Nicotine Metabolites and the Minor Tobacco Alkaloids—Anatabine and Anabasine—in Smokers' Urine
por: McGuffey, James E., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p19eie4i8fsevvpvataugmi1mp